ArticleCancers2024

Targeting PARP-1 and DNA Damage Response Defects in Colorectal Cancer Chemotherapy with Established and Novel PARP Inhibitors.

Philipp Demuth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.